NanoViricides Inc (NNVC)

[drkazmd65]

New Promotional Video: NanoViricides unimpacted by tariffs; sees boost by changes at government agencies

https://www.proactiveinvestors.com/companies/news/1069162/nanoviricides-unimpacted-by-tariffs-sees-boost-by-changes-at-government-agencies.html

Near the end of the written portion of the article:
In light of recent USDA funding initiatives aimed at combating H5N1 avian flu, Vyas said the company is keen to explore applications of NV-387 in that space as well. Currently, NanoViricides is conducting a Phase 2 clinical trial targeting smallpox, following successful Phase 1 results with no reported adverse effects.

First - Monkeypox - not Smallpox
Second - If they actually had started dosing patients for a Phase 2 trial - shouldn't they already have stated this as it would be material to investors or potential investors in the company?
Third - How are they currently funding this, assuming that an actual trial is taking place?